Detalhe da pesquisa
1.
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.
Blood
; 137(10): 1365-1376, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32992344
2.
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs.
Leukemia
; 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38877102
3.
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage.
Blood
; 114(26): 5307-14, 2009 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19850740
4.
Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 164(4): 425-434, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558845
5.
Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience.
Leuk Res
; 81: 75-81, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054420
6.
Fragment analysis represents a suitable approach for the detection of hotspot c.7541_7542delCT NOTCH1 mutation in chronic lymphocytic leukemia.
Leuk Res
; 60: 145-150, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28837890
7.
COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Leuk Lymphoma
; 58(1): 70-79, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27185377
8.
Specific p53 mutations do not impact results of alemtuzumab therapy among patients with chronic lymphocytic leukemia.
Leuk Lymphoma
; 53(9): 1817-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22263566